4893 items matching your search terms.

Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy

Basu, A. Yu, J. Y. Jenkins, A. J. Nankervis, A. J. Hanssen, K. F. Henriksen, T. Lorentzen, B. Garg, S. K. Menard, M. K. Hammad, S. M. Scardo, J. A. Aston, C. E. Lyons, T. J.
NUTRITION RESEARCH, 2015     DOI:10.1016/j.nutres.2015.04.004

PARAGON: an ANZGOG phase II study of anastrazole in asymptomatic women with estrogen/progesterone positive ovarian cancer with a CA125 progression after first line treatment

Beale, P. O'Connell, R. Scurry, J. Sjoquist, K. Martyn, J. Cannan, D. Bonaventura, T. Grant, P. Goh, J. Antill, Y. Friedlander, M.

Gender differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications?

Benitez-Aguirre, P. Z. Craig, M. E. Cass, H. G. Sugden, C. J. Jenkins, A. Wang, J. J. Cusumano, J. Hodgson, L. A. Lee, K. Wong, T. Y. Donaghue, K. C.
INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE, 2015     DOI:10.1167/iovs.14-15147

Patients' preferences for adjuvant sorafenib after resection of intermediate or high risk renal cell carcinoma in the sorce trial: What makes it worthwhile?

Blinman, P. Davis, I. Martin, A. Troon, S. Sengupta, S. Hovey, E. Coskinas, X. Kaplan, R. Ritchie, A. Meade, A. Eisen, T. Stockler, M.

Patients’ and doctors’ preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile?

Blinman, P. Hughes, B. Crombie, C. Christmas, T. Hudson, M. Veillard, A.S. Muljadi, N. Millward, M. Wright, G. Flynn, P. Windsor, M. Stockler, M. McLachlan, S.A.
EUROPEAN JOURNAL OF CANCER, 2015     DOI:10.1016/j.ejca.2015.05.022

Patients' preferences for adjuvant sorafenib after resection of intermediate or high-risk renal cell carcinoma in the SORCE trial: What makes it worthwhile?

Blinman, P.L. Davis, I.D. Martin, A. Troon, S. Sengupta, S. Hovey, E.J. Coskinas, X. Kaplan, R.S. Ritchie, A.W.S. Meade, A.M. Eisen, T. Stockler, M.R.

Optimising the screening process in a large , phase 3, multi-centre clinical trial

Bracken, K. Hague, W. Wittert, G. and the T4DM Study Team,

Single agent high dose cyclophosphamide for graft-versus-host disease prophylaxis in HLA-matched reduced intensity peripheral blood stem cell transplantation results in an unacceptably high rate of severe acute GVHD

Bradstock, K. F. Bilmon, I. Kwan, J. Micklethwaite, K. Blyth, E. Deren, S. Bayley, A. Gebski, V. Gottlieb, D.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015     DOI:10.1016/j.bbmt.2015.01.020

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance

Brennan, D. J. Hackethall, A. Mann, K.P. Mutz-Dehbalaie, I. Fiegl, H. Marth, C. Obermair, A.
BMC CANCER, 2015     DOI:10.1186/s12885-015-1028-0

The utility of screening logs collected in a perinatal trial of deferred cord clamping

Brown, R. Sebastian, L. Gill, A Tarnow-Mordi, W. Hague, W.

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

Brule, S. Y. Jonker, D. J. Karapetis, C. S. O'Callaghan, C. J. Moore, M. J. Wong, R. Tebbutt, N. C. Underhill, C. Yip, D. Zalcberg, J. R. Tu, D. Goodwin, R. A.
EUROPEAN JOURNAL OF CANCER, 2015     DOI:10.1016/j.ejca.2015.03.015

First-line chemotherapy in advanced biliary tract cancer: an Australian experience

Brungs, D. Aghmesheh, M. Sjoquist, K. Goldstein, D.

Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene

Burdon, K. P. Fogarty, R. D. Shen, W. Abhary, S. Kaidonis, G. Appukuttan, B. Hewitt, A. W. Sharma, S. Daniell, M. Essex, R. W. Chang, J. H. Klebe, S. Lake, S. R. Pal, B. Jenkins, A. Govindarjan, G. Sundaresan, P. Lamoureux, E. L. Ramasamy, K. Pefkianaki, M. Hykin, P. G. Petrovsky, N. Brown, M. A. Gillies, M. C. Craig, J. E.
DIABETOLOGIA, 2015     DOI:10.1007/s00125-015-3697-2

Mobilehealth RCT: an oxymoron?

Bursell, S.E.

Multidimensional poverty and health status as a predictor of chronic income poverty

Callander, E. Schofield, D.J.
HEALTH ECONOMICS, 2015     DOI:10.1002/hec.3112